Myositis‐specific autoantibodies: an important tool to support diagnosis of myositis
Tóm tắt
The idiopathic inflammatory myopathies are characterized by muscle weakness, skin disease and internal organ involvement. Autoimmunity is known to have a role in myositis pathogenesis, and myositis‐specific autoantibodies, targeting important intracellular proteins, are regarded as key biomarkers aiding in the diagnosis of patients. In recent years, a number of novel myositis autoantibodies including anti‐
Từ khóa
Tài liệu tham khảo
Phan TG, 2002, Autoantibodies to extractable nuclear antigens: making detection and interpretation more meaningful, Clin Diagn Lab Immunol, 9, 1
Kavanaugh A, 2000, Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists, Arch Pathol Lab Med, 124, 71, 10.5858/2000-124-0071-GFCUOT
Plestilova L, 2012, Anti‐PM‐Scl autoantibodies in polymyositis and dermatomyositis, Ann Rheum Dis, 71, 240
Feldman BM, 1996, Clinical significance of specific autoantibodies in juvenile dermatomyositis, J Rheumatol, 23, 1794
Targoff I, 2006, Autoantibodies to transcriptional intermediary factor 1‐gamma (TIF1‐g) in dermatomyositis, Arthritis Rheum, 54, 518
Matsuura E, 2012, Two young‐adult female cases of dermatomyositis with antibodies for transcriptional intermediary factor 1‐gamma, Eur J Dermatol, 22, 668, 10.1684/ejd.2012.1824
Oddis C, 1997, Clinical and serological characterisationof the anti‐MJ antibody in childhood myositis, Arthritis Rheum, 40, 139
Targoff I, 2007, Sera with autoantibodies to the MJ antigen react with NXP2, Arthritis Rheum, 56, 787
Tansley S, 2012, Clinical differences between adult and juvenile dermatomyositis assocaited with anti‐NXP2 autoantibodies, Arthritis Rheum, 64, S229
Shinjo SK, 2013, Update on the treatment of calcinosis in dermatomyositis, Rev Bras Reumatol, 53, 211
Betteridge Z, 2012, Clinical phenotypes of Caucasian adult and juvenile dermatomyosits patients with anti‐MDA5 autoantibodies, Arthritis Rheum, 64, S715
Ceribelli A, 2014, Prevalence and clinical significance of anti‐MDA5 antibodies in European patients with polymyositis/dermatomyositis, Clin Exp Rheumatol, 32, 891
Rouster‐Stevens KA, 2008, Autoantibody to signal recognition particle in African American girls with juvenile polymyositis, J Rheumatol, 35, 927
Mammen AL, 2012, Increased frequency of DRB1*11:01 in anti‐hydroxymethylglutaryl‐coenzyme A reductase‐associated autoimmune myopathy, Arthritis Care Res, 64, 1233, 10.1002/acr.21671
Pluk H, 2011, Anti‐Mup44: the first inclusion body myositis‐specific autoantibody, Autoantigens Autoantibodies AutoImmun, 7, 210
Herbert MK, 2015, Disease specificity of autoantibodies to cytosolic 5’‐nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases, Ann Rheum Dis